Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Vanderbilt University Medical Center1985 - 1986- University of Texas Health Science Center at Dallas1983 - 1985
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Illinois College of MedicineClass of 1980
Certifications & Licensure
IL State Medical License 1981 - 2026
TN State Medical License 1986 - 2026
KY State Medical License 1999 - 2025
AL State Medical License 2020 - 2020
FL State Medical License 2012 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 964 citationsSotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L. Bhatt, Michael Szarek, P. Gabriel Steg, Christopher P. Cannon, Lawrence A. Leiter
The New England Journal of Medicine. 2021-01-14 - 580 citationsSotagliflozin in Patients with Diabetes and Chronic Kidney Disease.Deepak L. Bhatt, Michael Szarek, Bertram Pitt, Christopher P. Cannon, Lawrence A. Leiter
The New England Journal of Medicine. 2021-01-14 - 4130 citationsRenoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesEdmond J Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomas Berl, Marc A. Pohl
The New England Journal of Medicine. 2001-09-20
Press Mentions
FDA Panel Backs Entresto, Spironolactone for Broader HF UseDecember 16th, 2020- Effects of 2 Drug Classes Compared in Advanced Chronic Kidney DiseaseDecember 10th, 2020
Study Addresses Barriers to Kidney Disease Screening Among Black AmericansMarch 16th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
